Bio X Cell InVivoSIM™

Biosimilar monoclonal antibodies - with 15% discount

Bio X CellBio X Cell InVivoSIM™ non-therapeutic antibodies are research-grade biosimilar monoclonal antibodies that have the same active biological component as the original therapeutic antibodies. Biosimilars make it possible to study the biological effects of a drug without the need to source an expensive pharmaceutical-grade therapeutic.


Features of Bio X Cell InVivoSIM™ antibodies:

  • greater than 95% purity
  • free of preservatives, stabilizers, and carrier proteins
  • screened for murine pathogens and protein aggregation
  • binding validation via immunoblot
  • less than 1 endotoxin unit per milligram guaranteed


InVivoSIM™ antibodies are for Research Use Only (RUO) and are not for therapeutic use.

Art. Nr. Product Name Applications
BXC-SIM0001 InVivoSIM™ anti-human TNFα (Adalimumab Biosimilar) TNFα neutralization; FC, ELISA; IF; IP; IHC; WB
BXC-SIM0002 InVivoSIM™ anti-human EGFR (Cetuximab Biosimilar) GFR blockade; ELISA; FC
BXC-SIM0003 InVivoSIM™ anti-human PD-1 (Nivolumab Biosimilar) Blocking of PD-1/PD-L signaling; FC; IHC; WB
BXC-SIM0004 InVivoSIM™ anti-human CTLA-4 (Ipilimumab Biosimilar) CTLA-4 neutralization; FC; ELISA; WB
BXC-SIM0005 InVivoSIM™ anti-human HER2 (Trastuzumab Biosimilar) FC; ELISA; IHC; WB
BXC-SIM0006 InVivoSIM™ anti-human TNFα (Infliximab Biosimilar) TNFα neutralization; FC; ELISA; WB
BXC-SIM0007 InVivoSIM™ anti-human VEGF (Bevacizumab Biosimilar) VEGF neutralization; FC; ELISA; IP
BXC-SIM0008 InVivoSIM™ anti-human CD20 (Rituximab Biosimilar) FC; ELISA; WB
BXC-SIM0009 InVivoSIM™ anti-human PD-L1 (Atezolizumab Biosimilar) FC; WB
BXC-SIM0010 InVivoSIM™ anti-human PD-1 (Pembrolizumab Biosimilar) FA
BXC-SIM0011 InVivoSIM™ anti-human C5 (Eculizumab Biosimilar) FA, ELISA, IP
BXC-SIM0012 InVivoSIM™ anti-human VEGFR-2 (Ramucirumab Biosimilar) FA, IHC, FC
BXC-SIM0013 InVivoSIM™ anti-human IL-17A (Secukinumab Biosimilar) FA, ELISA, IF, IHC, FC
BXC-SIM0014 InVivoSIM™ anti-human IL-6R (Tocilizumab Biosimilar) FA, ELISA
BXC-SIM0015 InVivoSIM™ anti-human LAG-3 (Relatlimab Biosimilar) ELISA
BXC-SIM0016 InVivoSIM™ anti-human IgE (Omalizumab Biosimilar) ELISA, FC



Other News

GeneTex Webinar: Ovarian cancer formation and spread

GeneTex Webinar

Ovarian cancer formation and spread

Meet us at the BIOZOL Booth

March Conferences

Meet BIOZOL in Göttingen, Ulm, and Munich

Mabtech Webinar: How to succeed with ELISpot

How to succeed with...

Live Webinar from Mabtech

Human Pluripotent Stem Cell Differentiation

Human Pluripotent St...

Differentiation Guide from Qkine

BIOZOL acquires AlphaScience

BIOZOL acquires Alph...

AlphaScience part of BIOZOL